Skip to main content
TipRanks
Go Ultimate75% OFF

Palatin Technologies (PTN) Drug Pipeline

2,935 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Tirzepatide, BremelanotideObesityPhase IIActive Not RecruitingA Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of ObesityJun 05, 2024―
Pl8177Ulcerative Colitis, Ulcerative Colitis Acute, Ulcerative, Ulcerative Colitis FlarePhase IIActive Not RecruitingPhase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)May 25, 2022―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Palatin Technologies, Inc. (PTN) have in its pipeline
Palatin Technologies PTN is currently developing the following drugs: Tirzepatide, Bremelanotide, Pl8177. These drug candidates are in various stages of clinical development as the company works toward FDA approval.